Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Hypertension Reports
Erschienen in: Current Hypertension Reports 11/2016

01.11.2016 | Blood Pressure Monitoring and Management (J Cockcroft, Section Editor)

Isolated Systolic Hypertension in Young and Middle-Aged Adults

verfasst von: Yuichiro Yano, Donald M. Lloyd-Jones

Erschienen in: Current Hypertension Reports | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Young and middle-aged adults (ages ≤50 years) are increasingly prone to stroke, kidney disease, and worsening cardiovascular disease (CVD) mortality. An alarming increase in the prevalence of high blood pressure (BP) may underlie the adverse trend. However, there is often uncertainty in BP management for young and middle-aged adults. Isolated systolic hypertension (ISH) is one such example. Whether ISH in young and middle-aged adults represents “pseudo” or “spurious” hypertension is still being debated. ISH in young and middle-aged adults is a heterogeneous entity; some individuals appear to have increased stroke volume, whereas others have stiffened aortae, or both. One size does not seem to fit all in the clinical management of ISH in young and middle-aged adults. Rather than treating ISH as a monolithic condition, detailed phenotyping of ISH based on (patho)physiology and in the context of individual global cardiovascular risks would seem to be most useful to assess an individual expected net benefit from therapy. This review provides an overview of the current understanding of ISH in young and middle-aged adults, including the prevalence, pathophysiology, and treatment.
Literatur
1.
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38–3602.CrossRefPubMed
2.
Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol. 2007;50:2128–32.CrossRefPubMed
3.
Kissela BM, Khoury JC, Alwell K, Moomaw CJ, Woo D, Adeoye O, et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology. 2012;79:1781–7.CrossRefPubMedPubMedCentral
4.
Kittner SJ, Singhal AB. Premature atherosclerosis: a major contributor to early-onset ischemic stroke. Neurology. 2013;80:1272–3.CrossRefPubMed
5.
6.
George MG, Tong X, Kuklina EV, Labarthe DR. Trends in stroke hospitalizations and associated risk factors among children and young adults, 1995–2008. Ann Neurol. 2011;70:713–21.CrossRefPubMed
7.
8.
Nguyen QC, Tabor JW, Entzel PP, Lau Y, Suchindran C, Hussey JM, et al. Discordance in national estimates of hypertension among young adults. Epidemiology. 2011;22:532–41.CrossRefPubMedPubMedCentral
9.
Parker ED, Sinaiko AR, Kharbanda EO, Margolis KL, Daley MF, Trower NK, et al. Change in weight status and development of hypertension. Pediatrics. 2016;137:1–9.CrossRef
10.
Suglia SF, Clark CJ, Gary-Webb TL. Adolescent obesity, change in weight status, and hypertension: racial/ethnic variations. Hypertension. 2013;61:290–5.CrossRefPubMed
11.
Rosner B, Cook NR, Daniels S, Falkner B. Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988–2008. Hypertension. 2013;62:247–54.CrossRefPubMedPubMedCentral
12.
Franklin SS, Wilkinson IB, McEniery CM. Unusual hypertensive phenotypes: what is their significance? Hypertension. 2012;59:173–8.CrossRefPubMed
13.
O’Rourke MF, Adji A. Guidelines on guidelines: focus on isolated systolic hypertension in youth. J Hypertens. 2013;31:649–54.CrossRefPubMed
14.
McEniery CM, Franklin SS, Wilkinson IB, Cockcroft JR. Isolated systolic hypertension in the young: a need for clarity. J Hypertens. 2013;31:1911–3.CrossRefPubMed
15.••
McEniery CM, Franklin SS, Cockcroft JR, Wilkinson IB. Isolated systolic hypertension in young people is not spurious and should be treated: pro side of the argument. Hypertension. 2016;68:269–75. This manuscript well summarizes clinical relevance of ISH in young adults.CrossRefPubMed
16.••
Lurbe E, Redon J. Isolated systolic hypertension in young people is not spurious and should be treated: con side of the argument. Hypertension. 2016;68:276–80. This manuscript well summarizes clinical relevance of ISH in young adults.CrossRefPubMed
17.
Grebla RC, Rodriguez CJ, Borrell LN, Pickering TG. Prevalence and determinants of isolated systolic hypertension among young adults: the 1999–2004 US National Health And Nutrition Examination Survey. J Hypertens. 2010;28:15–23.CrossRefPubMedPubMedCentral
18.
Liu X, Rodriguez CJ, Wang K. Prevalence and trends of isolated systolic hypertension among untreated adults in the United States. J Am Soc Hypertens. 2015;9:197–205.CrossRefPubMedPubMedCentral
19.
Franklin SS, Jacobs MJ, Wong ND, L’Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension. 2001;37:869–74.CrossRefPubMed
20.
Franklin SS, Barboza MG, Pio JR, Wong ND. Blood pressure categories, hypertensive subtypes, and the metabolic syndrome. J Hypertens. 2006;24:2009–16.CrossRefPubMed
21.••
Yano Y, Stamler J, Garside DB, Daviglus ML, Franklin SS, Carnethon MR, et al. Isolated systolic hypertension in young and middle-aged adults and 31-year risk for cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study. J Am Coll Cardiol. 2015;65:327–35. This is the strongest evidence so far revealing CVD risk associated with ISH in young and middle-aged adults.CrossRefPubMedPubMedCentral
22.
Mallion JM, Hamici L, Chatellier G, Lang T, Plouin PF, De Gaudemaris R. Isolated systolic hypertension: data on a cohort of young subjects from a French working population (IHPAF). J Hum Hypertens. 2003;17:93–100.CrossRefPubMed
23.
Saladini F, Dorigatti F, Santonastaso M, Mos L, Ragazzo F, Bortolazzi A, et al. Natural history of hypertension subtypes in young and middle-age adults. Am J Hypertens. 2009;22:531–7.CrossRefPubMed
24.
O’Rourke MF, Vlachopoulos C, Graham RM. Spurious systolic hypertension in youth. Vasc Med. 2000;5:141–5.CrossRefPubMed
25.
Avolio AP, Van Bortel LM, Boutouyrie P, Cockcroft JR, McEniery CM, Protogerou AD, et al. Role of pulse pressure amplification in arterial hypertension: experts’ opinion and review of the data. Hypertension. 2009;54:375–83.CrossRefPubMed
26.••
McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson IB. Central blood pressure: current evidence and clinical importance. Eur Heart J. 2014;35:1719–25. This is a well-written review describing clinical relevance of central BP.CrossRefPubMedPubMedCentral
27.
Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213–25.CrossRefPubMed
28.
Pini R, Cavallini MC, Palmieri V, Marchionni N, Di Bari M, Devereux RB, et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol. 2008;51:2432–9.CrossRefPubMed
29.
Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291–7.CrossRefPubMed
30.
Pimenta E, Oparil S. Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol. 2010;6:21–30.CrossRefPubMed
31.
Mahmud A, Feely J. Spurious systolic hypertension of youth: fit young men with elastic arteries. Am J Hypertens. 2003;16:229–32.CrossRefPubMed
32.
McEniery CM, Yasmin, Wallace S, Maki-Petaja K, McDonnell B, Sharman JE, et al. Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults. Hypertension. 2005;46:221–6.CrossRefPubMed
33.
Hulsen HT, Nijdam ME, Bos WJ, Uiterwaal CS, Oren A, Grobbee DE, et al. Spurious systolic hypertension in young adults; prevalence of high brachial systolic blood pressure and low central pressure and its determinants. J Hypertens. 2006;24(6):1027–33.CrossRefPubMed
34.
Higashino R, Miyaki A, Kumagai H, Choi Y, Akazawa N, Ra SG, et al. Effects of lifestyle modification on central blood pressure in overweight and obese men. Blood Press Monit. 2013;18:311–5.CrossRefPubMed
35.
Westerbacka J, Vehkavaara S, Bergholm R, Wilkinson I, Cockcroft J, Yki-Järvinen H. Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes. 1999;48:821–7.CrossRefPubMed
36.
Saladini F, Santonastaso M, Mos L, Benetti E, Zanatta N, Maraglino G, et al. Isolated systolic hypertension of young-to-middle-age individuals implies a relatively low risk of developing hypertension needing treatment when central blood pressure is low. J Hypertens. 2011;29:1311–9.PubMed
37.
McEniery CM, Yasmin, McDonnell B, Munnery M, Wallace SM, Rowe CV, et al. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension. 2008;51:1476–82.CrossRefPubMed
38.
Protogerou AD, Blacher J, Mavrikakis M, Lekakis J, Safar ME. Increased pulse pressure amplification in treated hypertensive subjects with metabolic syndrome. Am J Hypertens. 2007;20:127–33.CrossRefPubMed
39.
McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR, et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46:1753–60.CrossRefPubMed
40.
Camacho F, Avolio A, Lovell NH. Estimation of pressure pulse amplification between aorta and brachial artery using stepwise multiple regression models. Physiol Meas. 2004;25:879–89.CrossRefPubMed
41.
Vlachopoulos C, O’Rourke M. Diastolic pressure, systolic pressure, or pulse pressure? Curr Hypertens Rep. 2000;2:271–9.CrossRefPubMed
42.
Safar ME. Arterial aging—hemodynamic changes and therapeutic options. Nat Rev Cardiol. 2010;7:442–9.CrossRefPubMed
43.
Franklin SS, Gustin 4th W, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308–15.CrossRefPubMed
44.
Nichols WW, O’Rourke MF. McDonald’s blood flow in arteries. Philadelphia: Lea & Febiger; 1990.
45.
Berne RM, Levy MN. Cardiovascular physiology. 6th ed. St Louis: Mosby Year Book; 1992. p. 135–51.
46.
Messerli FH, Frohlich ED, Suarez DH, Reisin E, Dreslinski GR, Dunn FG, et al. Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines. Circulation. 1981;64:760–4.CrossRefPubMed
47.
Julius S, Pascual AV, London R. Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation. 1971;44:413–8.CrossRefPubMed
48.
Collis T, Devereux RB, Roman MJ, de Simone G, Yeh J, Howard BV, et al. Relations of stroke volume and cardiac output to body composition: the strong heart study. Circulation. 2001;103:820–5.CrossRefPubMed
49.
Mitchell GF, Conlin PR, Dunlap ME, Lacourcière Y, Arnold JM, Ogilvie RI, et al. Aortic diameter, wall stiffness, and wave reflection in systolic hypertension. Hypertension. 2008;51:105–11.CrossRefPubMed
50.
Dysart JM, Treiber FA, Pflieger K, Davis H, Strong WB. Ethnic differences in the myocardial and vascular reactivity to stress in normotensive girls. Am J Hypertens. 1994;7:15–22.PubMed
51.
McCarron P, Smith GD, Okasha M, McEwen J. Blood pressure in young adulthood and mortality from cardiovascular disease. Lancet. 2000;355(9213):1430–1.CrossRefPubMed
52.
Sundström J, Neovius M, Tynelius P, Rasmussen F. Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts. BMJ. 2011;342:d643.CrossRefPubMedPubMedCentral
53.
Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation. 2001;103:1245–9.CrossRefPubMed
54.
Miura K, Daviglus ML, Dyer AR, Liu K, Garside DB, Stamler J, et al. Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. Arch Intern Med. 2001;161:1501–8.CrossRefPubMed
55.
Paffenbarger Jr RS, Wing AL. Chronic disease in former college students. XI. Early precursors of nonfatal stroke. Am J Epidemiol. 1971;94:524–30.PubMed
56.
Gray L, Lee IM, Sesso HD, Batty GD. Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study). J Am Coll Cardiol. 2011;58:2396–403.CrossRefPubMedPubMedCentral
57.
Strandberg TE, Salomaa VV, Vanhanen HT, Pitkälä K, Miettinen TA. Isolated diastolic hypertension, pulse pressure, and mean arterial pressure as predictors of mortality during a follow-up of up to 32 years. J Hypertens. 2002;20:399–404.CrossRefPubMed
58.
Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, Smith WM. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation. 1988;77:504–14.CrossRefPubMed
59.
Pimenta E, Oparil S. Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol. 2010;6:21–30.CrossRefPubMed
60.
Shim CY, Park S, Choi D, Yang WI, Cho IJ, Choi EY, et al. Sex differences in central hemodynamics and their relationship to left ventricular diastolic function. J Am Coll Cardiol. 2011;57:1226–33.CrossRefPubMed
61.
Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878–84.CrossRefPubMed
62.
Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3–10.CrossRefPubMed
63.••
Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66:698–722.CrossRefPubMedPubMedCentral
64.
Dhakam Z, Yasmin, McEniery CM, Burton T, Brown MJ, Wilkinson IB. A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens. 2008;26:351–6.CrossRefPubMed
65.
Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis. 2012;221:18–33.CrossRefPubMed
Metadaten
Titel
Isolated Systolic Hypertension in Young and Middle-Aged Adults
verfasst von
Yuichiro Yano
Donald M. Lloyd-Jones
Publikationsdatum
01.11.2016
Verlag
Springer US
Erschienen in
Current Hypertension Reports / Ausgabe 11/2016
Print ISSN: 1522-6417
Elektronische ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-016-0686-x

Weitere Artikel der Ausgabe 11/2016

Current Hypertension Reports 11/2016 Zur Ausgabe

Pulmonary Hypertension (J Klinger, Section Editor)

Pulmonary Arterial Hypertension and the Sex Hormone Paradox

Hypertension and Obesity (E Reisin, Section Editor)

A Clinical Perspective: Contribution of Dysfunctional Perivascular Adipose Tissue (PVAT) to Cardiovascular Risk

Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor)

White Coat Hypertension: to Treat or Not to Treat?

Hypertension and Obesity (E Reisin, Section Editor)

Endoluminal Treatments for Obesity and Related Hypertension: Updates, Review, and Clinical Perspective

Antihypertensive Agents: Mechanisms of Drug Action (ME Ernst, Section Editor)

Effects of Aspirin on Endothelial Function and Hypertension

Resistant Hypertension (E Pimenta, Section Editor)

Should All Patients with Resistant Hypertension Receive Spironolactone?

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise